Novo Nordisk | NVO - Ordinary Share Capital

Stock Price
44.74
Daily Change
-1.10 -2.40%
Monthly
9.44%
Yearly
-30.48%
Q2 Forecast
42.62

Novo Nordisk reported DKK4.44B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bausch Health Companies USD 373.46M 2.93M Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Merck USD 2.47B 12.72M Dec/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Novo Nordisk DKK 4.44B 0 Dec/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pacira USD 39.31M 1.81M Mar/2026
Perrigo USD 138.1M 500K Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026